1
|
Tirapelli CR, Legros E, Brochu I, Honoré JC, Lanchote VL, Uyemura SA, de Oliveira AM, D'Orléans-Juste P. Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats. Br J Pharmacol 2008; 154:971-81. [PMID: 18469849 DOI: 10.1038/bjp.2008.157] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND AND PURPOSE The contribution of endothelin-1 (ET-1) to vascular hyper-reactivity associated with chronic ethanol intake, a major risk factor in several cardiovascular diseases, remains to be investigated. EXPERIMENTAL APPROACH The biphasic haemodynamic responses to ET-1 (0.01-0.1 nmol kg(-1), i.v.) or to the selective ETB agonist, IRL1620 (0.001-1.0 nmol kg(-1), i.v.), with or without ETA or ETB antagonists (BQ123 (c(DTrp-Dasp-Pro-Dval-Leu)) at 1 and 2.5 mg kg(-1) and BQ788 (N-cis-2,6-dimethyl-piperidinocarbonyl-L-gamma-methylleucyl1-D-1methoxycarbonyltryptophanyl-D-norleucine) at 0.25 mg kg(-1), respectively) were tested in anaesthetized rats, after 2 weeks' chronic ethanol treatment. Hepatic parameters and ET receptor protein levels were also determined. KEY RESULTS The initial hypotensive responses to ET-1 or IRL1620 were unaffected by chronic ethanol intake, whereas the subsequent pressor effects induced by ET-1, but not by IRL1620, were potentiated. BQ123 at 2.5 but not 1 mg kg(-1) reduced the pressor responses to ET-1 in ethanol-treated rats. Conversely, BQ788 (0.25 mg kg(-1)) potentiated ET-1-induced increases in mean arterial blood pressure in control as well as in ethanol-treated rats. Interestingly, in the latter group, increases in heart rate, induced by ET-1 at a dose of 0.025 mg kg(-1) were enhanced following ETB receptor blockade. Finally, we observed higher levels of ETA receptor in the heart and mesenteric artery and a reduction of ETB receptor protein levels in the aorta and kidney from rats chronically treated with ethanol. CONCLUSIONS AND IMPLICATIONS Increased vascular reactivity to ET-1 and altered protein levels of ETA and ETB receptors could play a role in the pathogenesis of cardiovascular complications associated with chronic ethanol consumption.
Collapse
Affiliation(s)
- C R Tirapelli
- Department of Pharmacology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada
| | | | | | | | | | | | | | | |
Collapse
|
2
|
Legros E, Tirapelli CR, Carrier E, Brochu I, Fournier A, D'Orléans-Juste P. Characterization of the non-adrenergic/non-cholinergic response to perivascular nerve stimulation in the double-perfused mesenteric bed of the mouse. Br J Pharmacol 2007; 152:1049-59. [PMID: 17906682 PMCID: PMC2095099 DOI: 10.1038/sj.bjp.0707475] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND AND PURPOSE Calcitonin gene-related peptide (CGRP), a capsaicin-sensitive neuromodulator of splanchnic vascular tone in several animal species, remains poorly investigated in mouse models. We therefore assessed whether endogenous CGRP is a non-adrenergic/non-cholinergic (NANC) neuromodulator in the mesenteric vascular bed of the mouse. EXPERIMENTAL APPROACH Arterial and venous changes in perfusion pressure in response to perivascular nerve stimulation (PNS) were monitored in the mouse mesenteric bed under basal conditions or precontracted with KCl (artery) or U46619 (vein) in circuits pretreated with guanethidine, atropine, indomethacin and prazosin. Arterial responses to NANC were also characterized with a CGRP1 antagonist, halphaCGRP8-37. Finally, the PNS-induced release of arterial CGRP was measured by enzyme immunoassay. KEY RESULTS HalphaCGRP8-37 enhanced PNS-induced arterial increases in perfusion pressure under basal tone. PNS-induced stimulation of NANC triggered an halphaCGRP8-37 or capsaicin- sensitive reduction in perfusion pressure of the pre-contracted arterial bed only. Chemical removal of the endothelium inhibited PNS- and halphaCGRP- induced reduction in perfusion pressure in the arterial mesenteric bed. Responses to NANC nerves were reduced by guanylate and adenylate cyclase inhibitors (1H-[1,2,4]oxadiazole[4,3-a] quinoxalin-1-one (ODQ)) and [9-(tetrahydro-2-furanyl)-9H-purin-6-amine] (SQ 22,536), respectively. A neuronal NOS inhibitor (7-nitroindazole; 7-NI) also enhanced the response to NANC in vessels from wild-type, eNOS KO but not iNOS KO mice. Finally, PNS enhanced the release of immunoreactive CGRP from the perfused arterial mesenteric bed. CONCLUSIONS AND IMPLICATIONS Our study demonstrates a role for CGRP in the NANC-dependent reduction in perfusion pressure of the arterial but not venous mesenteric bed of the mouse.
Collapse
Affiliation(s)
- E Legros
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke Sherbrooke, Québec, Canada
| | - C R Tirapelli
- Department of Psychiatry Nursing and Human Sciences, College of Nursing of Ribeirao Preto, University of Sao Paulo (USP) Ribeirao Preto, Brazil
| | - E Carrier
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke Sherbrooke, Québec, Canada
| | - I Brochu
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke Sherbrooke, Québec, Canada
| | - A Fournier
- INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laboratoire d'études moléculaires et, pharmacologiques des peptides Pointe-Claire (Montréal), Québec, Canada
| | - P D'Orléans-Juste
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke Sherbrooke, Québec, Canada
- Author for correspondence:
| |
Collapse
|
3
|
Tirapelli CR, Casolari DA, Yogi A, Tostes RC, Legros E, Lanchote VL, Uyemura SA, de Oliveira AM. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol 2007; 41:77-85. [PMID: 17466482 DOI: 10.1016/j.alcohol.2007.02.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2006] [Revised: 01/16/2007] [Accepted: 02/09/2007] [Indexed: 12/27/2022]
Abstract
The purpose of the present work was to investigate whether conversion of exogenous applied big-endothelin-1 (Big-ET-1) as well as the basal release and mRNA levels of endothelin-1 (ET-1) is altered by ethanol consumption in the rat carotid. The measurement of the contraction induced by Big-ET-1 served as an indicative of functional endothelin (ET)-converting enzyme (ECE) activity. Cumulative application of exogenous Big-ET-1 elicited a concentration-related contraction with the concentration-response curve shifted to the right when compared to ET-1. In endothelium-intact rings, phosphoramidon (1 mmol/l), a nonselective ECE/neutral endopeptidase (NEP) inhibitor, produced a rightward displacement of the concentration-response curves and reduced the maximal contractile response to Big-ET-1. However, in endothelium-denuded rings phosphoramidon reduced the maximum contraction for Big-ET-1 but did not alter the potency when compared to the curves obtained in the absence of the inhibitor. Ethanol consumption for 2, 6, or 10 weeks reduced the contractile effect elicited by Big-ET-1 in carotid rings with intact endothelium when compared to control or isocaloric rings. However, no differences on Big-ET-1-induced contraction were observed after endothelial denudation. On the other hand, ethanol consumption increased ET-1-induced contraction. Finally, chronic ethanol consumption did not alter either the mRNA levels for pre-pro-ET-1 nor the basal release of ET-1. The present findings show that chronic ethanol consumption does not alter the mRNA levels for ET-1 or its basal release in the rat carotid. Moreover, ethanol intake reduces the contraction induced by exogenously applied Big-ET-1 in carotid rings with intact endothelium, a fact that might be the result of a reduced conversion of this peptide by ECE on its mature active peptide ET-1.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Psychiatry Nursing and Human Sciences, College of Nursing of Ribeirão Preto, University of São Paulo (USP), SP, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Tirapelli CR, Casolari DA, Montezano AC, Yogi A, Tostes RC, Legros E, D'Orléans-Juste P, Lanchote VL, Uyemura SA, de Oliveira AM. Ethanol consumption enhances endothelin-1-induced contraction in the isolated rat carotid. J Pharmacol Exp Ther 2006; 318:819-27. [PMID: 16651399 DOI: 10.1124/jpet.106.103010] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
We investigated the mechanisms involved in the enhancement of endothelin (ET)-1 vascular reactivity induced by ethanol consumption. Ethanol intake for 2, 6, and 10 weeks enhanced the ET-1-induced contractile response of endothelium-intact but not endothelium-denuded rat carotid rings independently of the treatment duration. Conversely, phenylephrine-induced contraction was not affected by ethanol intake. The contraction induced by IRL1620 [succinyl-(Glu(9),Ala(11,15))-ET-1-(8-21)], a selective ET(B) agonist, was increased after treatment with ethanol in endothelium-intact but not in endothelium-denuded carotid rings. Moreover, ET-1- and IRL1620-induced relaxation was reduced in endothelium-intact phenylephrine-precontracted rings from ethanol-treated rats. Acetylcholine-induced relaxation was not affected by ethanol treatment. N(G)-Nitro-l-arginine methyl ester, 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one, indomethacin, and tetraethylammonium reduced the relaxation induced by IRL1620 in carotid glands from control but not ethanol-treated rats. The mRNA levels for ET(A) and ET(B) receptors were not altered by ethanol consumption. However, ethanol treatment reduced the protein expression of ET(B) receptors. Furthermore, immunohistochemical assays showed reduced immunostaining for endothelial ET(B) receptors after treatment with ethanol. We conclude that ethanol consumption enhances ET-1-induced contraction in the rat carotid and that this response is not different among the three periods of treatment used in this study. Finally, the potentiation of ET-1-induced vascular reactivity is probably caused by reduced expression of relaxing endothelial ET(B) receptors.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Tirapelli CR, Fecteau MH, Honore JC, Legros E, Gobeil F, D'orleans-Juste P. Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta. Br J Pharmacol 2006; 148:527-35. [PMID: 16633356 PMCID: PMC1751794 DOI: 10.1038/sj.bjp.0706735] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
We investigated whether blood vessels contribute to the production of ET-1(1-31) from exogenous big endothelin-1 (BigET-1) in the rabbit and assessed which enzymes are involved in this process. Vascular reactivity experiments, using standard muscle bath procedures, showed that BigET-1 induces contraction in endothelium-intact rabbit aortic rings. Preincubation of the rings with phosphoramidon, CGS35066 or thiorphan reduced BigET-1-induced contraction. Conversely, chymostatin did not affect BigET-1-induced contraction. Thiorphan and phosphoramidon, but not CGS35066 or chymostatin, reduced ET-1(1-31)-induced contraction. None of the enzymatic inhibitors affected the contraction afforded by ET-1.BQ123-, but not BQ788-, selective antagonists for ET(A) and ET(B) receptors, respectively, produced concentration-dependent rightward displacements of the ET-1(1-31) and ET-1 concentration-response curves. By the use of enzymatic assays, we found that the aorta, as well as the heart, lung, kidney and liver, possess a chymase-like activity. Enzyme immunoassays detected significant levels of Ir-ET-1(1-31) in bathing medium of aortas after the addition of BigET-1 (30 nM). Neither thiorphan nor chymostatin altered the levels of Ir-ET-1(1-31). Conversely, the levels of Ir-ET-1(1-31) were increased in the presence of phosphoramidon. This marked increase of the 31-amino-acid peptide was abolished when phosphoramidon and chymostatin were added simultaneously. The major new finding of the present work is that the rabbit aorta generates ET-1(1-31) from exogenously administered BigET-1. Additionally, by measuring the production of ET-1(1-31), we showed that a chymase-like enzyme is involved in this process when ECE and NEP are inhibited by phosphoramidon. Our results also suggest that ET-1(1-31) is an alternate intermediate in the production of ET-1 following BigET-1 administration. Finally, we showed that NEP is the predominant enzymatic pathway involved in the cleavage of ET-1(1-31) to a bioactive metabolite that will act on ET(A) receptors to induce contraction in the rabbit aorta.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
| | - Marie-Helene Fecteau
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
| | - Jean-Claude Honore
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
| | - Eurode Legros
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
| | - Fernand Gobeil
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
| | - Pedro D'orleans-Juste
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 – 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4
- Author for correspondence:
| |
Collapse
|
6
|
Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes RC, Legros E, D'Orléans-Juste P, de Oliveira AM. Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol 2005; 146:903-12. [PMID: 16151434 PMCID: PMC1751214 DOI: 10.1038/sj.bjp.0706388] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2005] [Revised: 05/05/2005] [Accepted: 08/05/2005] [Indexed: 11/09/2022] Open
Abstract
We aimed to functionally characterize endothelin (ET) receptors in the rat carotid artery. mRNA and protein expressions of both ETA and ETB receptors, evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and Western immunoblotting, were detected in carotid segments. Immunohistochemical assays showed that ETB receptors are expressed in the endothelium and smooth muscle cells, while ETA receptors are expressed only in the smooth muscle cells. In endothelium-denuded vessels, levels of ETB receptor mRNA were reduced. Vascular reactivity experiments, using standard muscle bath procedures, showed that ET-1 induces contraction in endothelium-intact and -denuded carotid rings in a concentration-dependent manner. Endothelial removal enhanced ET-1-induced contraction. BQ123 and BQ788, selective antagonists for ETA and ETB receptors, respectively, produced concentration-dependent rightward displacements of the ET-1 concentration-response curves. IRL1620, a selective agonist for ETB receptors, induced a slight vasoconstriction that was abolished by BQ788, but not affected by BQ123. IRL1620-induced contraction was augmented after endothelium removal. ET-1 concentration dependently relaxed phenylephrine-precontracted rings with intact endothelium. The relaxation was augmented in the presence of BQ123, reduced in the presence of BQ788 and completely abolished after endothelium removal. IRL1620 induced vasorelaxation that was abolished by BQ788 and endothelium removal, but not affected by BQ123. Preincubation of intact rings with N(G)-nitro-L-arginine methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), indomethacin or tetraethylammonium (TEA) reduced IRL1620-induced relaxation. The combination of L-NAME, indomethacin and TEA completely abolished IRL1620-induced relaxation while sulfaphenazole did not affect this response. 4-aminopyridine (4-AP), but not apamin, glibenclamide or charybdotoxin, reduced IRL1620-induced relaxation. The major finding of this work is that it firstly demonstrated functionally the existence of both ETA and ETB vasoconstrictor receptors located on the smooth muscle of rat carotid arteries and endothelial ETB receptors that mediated vasorelaxation via NO-cGMP pathway, vasodilator cyclooxygenase product(s) and the activation of voltage-dependent K+ channels.
Collapse
MESH Headings
- Animals
- Blotting, Western
- Carotid Arteries/drug effects
- Carotid Arteries/metabolism
- Carotid Arteries/physiology
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Endothelin-1/pharmacology
- Endothelins/pharmacology
- Endothelium, Vascular/physiology
- Endothelium-Dependent Relaxing Factors/physiology
- Gene Expression/drug effects
- Immunohistochemistry
- Male
- Nitric Oxide/physiology
- Oligopeptides/pharmacology
- Peptide Fragments/pharmacology
- Peptides, Cyclic/pharmacology
- Piperidines/pharmacology
- Potassium Channels/physiology
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Rats
- Rats, Wistar
- Receptor, Endothelin A/genetics
- Receptor, Endothelin A/physiology
- Receptor, Endothelin B/genetics
- Receptor, Endothelin B/physiology
- Reverse Transcriptase Polymerase Chain Reaction/methods
- Vasodilation/drug effects
- Vasodilation/physiology
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of São Paulo (USP), SP, Brazil
| | - Debora A Casolari
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Alvaro Yogi
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Augusto C Montezano
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Rita C Tostes
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Eurode Legros
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Universite de Sherbrooke, QC, Canada
| | - Pedro D'Orléans-Juste
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Universite de Sherbrooke, QC, Canada
| | - Ana M de Oliveira
- Department of Physics and Chemistry, Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, USP, Ribeirão Preto, SP, Brazil
| |
Collapse
|
7
|
Legros E. [Not Available]. Enquetes Mus Vie Wallonne 2001; 15:129-61. [PMID: 11634907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
8
|
Blanc V, Picaud J, Legros E, Bes M, Etienne J, Moatti D, Raynaud MF. [Infection after total hip replacement by Staphylococcus caprae. Case report and review of the literature]. Pathol Biol (Paris) 1999; 47:409-13. [PMID: 10418010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
We report a case of Staphylococcus caprae bone and joint infection, that illustrate difficulties to diagnose coagulase-negative staphylococci (CNS) orthopedic surgery infections, specially following implantation of prostheses. Four of 5 strains successivelly isolated from deep and/or peri-operative specimens during late infection after total hip replacement (THR) have been identified, using commercial systems and conventionnal tests, as S. caprae. Identity of biochemical profile, antibiotype and pulsotype of the 4 isolates confirmed the pathogenicity of this animal CNS, rarely described as a human pathogen. Analysis of the 24 S. caprae human cases previously described evidence a relation ship between this bacteria and bone and joint infections, with implantation of prosthetic material as supplementary risk factor. S. caprae, whose major identification criteria are resumed, may have previously been misidentified as some similar CNS; this bacteria is probably part of our normal flora but may be recognized as an opportunistic pathogen, responsible for both nosocomial and community acquired infections.
Collapse
Affiliation(s)
- V Blanc
- Laboratoire, Centre Hospitalier d'Antibes Juan-les-Pins, Antibes, France
| | | | | | | | | | | | | |
Collapse
|
9
|
|